Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13790-88-0

Post Buying Request

13790-88-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13790-88-0 Usage

Description

(1E)-7-fluoro-N-hydroxy-3,4-dihydronaphthalen-1(2H)-imine, also known as FDNI, is a synthetic compound derived from naphthalene with a fluorine atom and a hydroxyl group. It is used in research and development across pharmaceuticals, agrochemicals, and materials science due to its potential pharmacological activities and applications in creating materials with specific properties.

Uses

Used in Pharmaceutical Research and Development:
FDNI is utilized as a chemical intermediate for the synthesis of new pharmaceutical compounds. Its unique structure and properties make it a promising candidate for the development of drugs with novel mechanisms of action.
Used in Agrochemical Research and Development:
In the agrochemical industry, FDNI serves as a building block for the creation of new agrochemicals. Its potential to exhibit biological activities can lead to the development of innovative products for crop protection and pest control.
Used in Materials Science:
FDNI is employed in the field of materials science for the development of new materials with specific characteristics. Its chemical structure allows for the engineering of materials with tailored properties for various applications, such as in electronics, coatings, or advanced materials for industrial use.

Check Digit Verification of cas no

The CAS Registry Mumber 13790-88-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,7,9 and 0 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 13790-88:
(7*1)+(6*3)+(5*7)+(4*9)+(3*0)+(2*8)+(1*8)=120
120 % 10 = 0
So 13790-88-0 is a valid CAS Registry Number.

13790-88-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (NE)-N-(7-fluoro-3,4-dihydro-2H-naphthalen-1-ylidene)hydroxylamine

1.2 Other means of identification

Product number -
Other names 7-fluoro-quinoline

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13790-88-0 SDS

13790-88-0Relevant articles and documents

Design, synthesis and biological evaluation of brain penetrant benzazepine-based histone deacetylase 6 inhibitors for alleviating stroke-induced brain infarction

Guo, Zheng,Zhang, Zixue,Zhang, Yi,Wang, Guan,Huang, Ziyi,Zhang, Qinwei,Li, Jianqi

, (2021/04/02)

Histone deacetylase 6 (HDAC6) has become a promising therapeutic target for central nervous system diseases due to its more complex protein structure and biological functions. However, low brain penetration of reported HDAC6 inhibitors limits its clinical application in neurological disorders. Therefore, the benzazepine, a brain-penetrant rigid fragment, was utilized to design a series of selective HDAC6 inhibitors to improve brain bioavailability. Various synthetic strategies were applied to assemble the tetrahydro-benzazepine ring, and 22 compounds were synthesized. Among them, compound 5 showed low nanomolar potency and strong isozyme selectivity for the inhibition of HDAC6 (IC50 = 1.8 nM, 141-fold selectivity over HDAC1) with efficient binding patterns like coordination with the zinc ion and π-π stacking effect. Western blot results showed it could efficiently transport into SH-SY5Y cells and selectively enhance the acetylation level of α-tubulin with a moderate effect on Histone H3. Notably, pharmacokinetic studies demonstrated that compound 5 (brain/plasma ratio of 2.30) had an excellent ability to penetrate the blood-brain barrier of C57 mice. In male rats with transient middle cerebral artery occlusion (MCAO), compound 5 significantly reduced the cerebral infarction from 21.22% to 11.47% and alleviated neurobehavioral deficits in post-ischemic treatment, which provided a strong rationale for pursuing HDAC6-based therapies for ischemic stroke.

Pd-catalyzed Semmler-Wolff reactions for the conversion of substituted cyclohexenone oximes to primary anilines

Hong, Wan Pyo,Iosub, Andrei V.,Stahl, Shannon S.

supporting information, p. 13664 - 13667 (2013/10/01)

Homogeneous Pd catalysts have been identified for the conversion of cyclohexenone and tetralone O-pivaloyl oximes to the corresponding primary anilines and 1-aminonaphthalenes. This method is inspired by the Semmler-Wolff reaction, a classic method that exhibits limited synthetic utility owing to its forcing conditions, narrow scope, and low product yields. The oxime N-O bond undergoes oxidative addition to Pd0(PCy3)2, and the product of this step has been characterized by X-ray crystallography and shown to undergo dehydrogenation to afford the aniline product.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13790-88-0